补阳还五汤联合依达拉奉对小鼠急性脑缺血再灌注损伤的神经保护作用

被引:9
作者
钟芳芳
吴承龙
孙新芳
章燕幸
机构
[1] 绍兴市人民医院
关键词
补阳还五汤; 依达拉奉; 脑缺血再灌注; 细胞凋亡;
D O I
10.13748/j.cnki.issn1007-7693.2016.03.008
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
目的研究补阳还五汤联合依达拉奉对小鼠脑缺血再灌注损伤模型的保护作用。方法改良线栓法建立小鼠大脑中动脉缺血再灌注模型。小鼠随机分为假手术组、模型组、补阳还五汤组、依达拉奉组和补阳还五汤+依达拉奉组。术后1,3,7 d观察治疗后各组小鼠神经功能缺损评分。术后7 d,比较各组脑梗死体积大小,TUNEL法检测细胞凋亡。结果与假手术组比较,模型组小鼠神经缺损评分、脑梗死体积、凋亡细胞数均显著增加(P<0.01)。与模型组比较,各用药组神经缺损评分、脑梗死体积、凋亡细胞数均显著减少(P<0.05),且联合用药组以上指标均显著好于单用药组。结论补阳还五汤与依达拉奉联合用药对小鼠脑缺血再灌注损伤有协同神经保护作用,比单药使用更有效地抑制细胞凋亡。
引用
收藏
页码:293 / 297
页数:5
相关论文
共 9 条
[1]  
Neuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage[J]. Qingchun Mu,Pengfei Liu,Xitong Hu,Haijun Gao,Xu Zheng,Haiyan Huang. Neural Regeneration Research. 2014(17)
[2]   藤茶总黄酮对大鼠脑缺血再灌损伤的保护作用 [J].
罗淑萍 ;
郭炎荣 ;
杨青 .
中国现代应用药学, 2014, (06) :674-677
[3]   补阳还五汤抗脑缺血作用的研究进展 [J].
陈冬 ;
杨洁红 .
中华中医药学刊 , 2010, (01) :72-74
[4]  
Neuroprotective effects of edaravone: Recent insights[J] . Shailendra Kapoor. Journal of the Neurological Sciences . 2013 (1-2)
[5]  
Neuroprotective effect of Buyang Huanwu Decoction against focal cerebral ischemia/reperfusion injury in rats – Time window and mechanism[J] . Lian-Dong Zhao,Jian-Hua Wang,Guang-Rong Jin,Ying Zhao,Hai-Jun Zhang. Journal of Ethnopharmacology . 2012 (2)
[6]   Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice [J].
Wang, Hsei-Wei ;
Liou, Kuo-Tong ;
Wang, Yea-Hwey ;
Lu, Chung-Kuang ;
Lin, Yun-Lian ;
Lee, I-Jung ;
Huang, Sheng-Teng ;
Tsai, Yuan-Hau ;
Cheng, Yi-Chieh ;
Lin, Hung-Jui ;
Shen, Yuh-Chiang .
JOURNAL OF ETHNOPHARMACOLOGY, 2011, 138 (01) :22-33
[7]  
Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury[J] . P. Zhang,W. Li,L. Li,N. Wang,X. Li,M. Gao,J. Zheng,S. Lei,X. Chen,H. Lu,Y. Liu. Neuroscience . 2011
[8]  
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial[J] . Hans-Christoph Diener,Julien Bogousslavsky,Lawrence M Brass,Claudio Cimminiello,Laszlo Csiba,Markku Kaste,Didier Leys,Jordi Matias-Guiu,Hans-Jürgen Rupprecht. The Lancet . 2004 (9431)
[9]   Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat [J].
Chen, JL ;
Li, Y ;
Katakowski, M ;
Chen, XG ;
Wang, L ;
Lu, DY ;
Lu, M ;
Gautam, SC ;
Chopp, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (06) :778-786